- $44.06bn
- $116.91bn
- £29.11bn
- 57
- 96
- 100
- 98
2019 December 31st | 2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Interest Income | |||||
Interest Expense | |||||
Net Interest Income | 9,366 | 8,088 | 8,073 | 10,572 | 12,709 |
Loan Loss Provision | |||||
Net Interest Income After Loan Loss Provision | 7,454 | 6,373 | 8,726 | 9,352 | 10,828 |
Non Interest Income | |||||
Non Interest Expense | |||||
Net Income Before Taxes | 4,357 | 3,065 | 8,194 | 7,012 | 6,557 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,354 | 2,461 | 7,056 | 5,973 | 5,323 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,274 | 2,383 | 7,009 | 5,928 | 5,259 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,461 | 1,526 | 6,205 | 5,023 | 4,274 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.229 | 0.255 | 0.426 | 0.388 | 0.312 |
Dividends per Share |